Cancer

At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Kolling Institute Tumour Bank

Events, News and Seminars

Cancer experts going from strength to strength

Cancer experts going from strength to strength

A special visit by two international cancer specialists could mark the start of a valuable collabora..... Read more

Category: Presentations, Research Excellence

Partnership to drive innovation in genomic science

Partnership to drive innovation in genomic science

An exciting partnership between AGRF Ltd (Australian Genome Research Facility) and the University of..... Read more

Category: New Treatment, Research Excellence

Kolling Research Symposium 2024

Kolling Research Symposium 2024

We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, ..... Read more

Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Presentations, Research Excellence